Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Malgorzata Gil-Moore
Observed names:
Malgorzata Gil‐Moore,
Malgorzata Gil‑Moore
Institution:
Vaccinex (United States)
Observed institutions:
Roswell Park Comprehensive Cancer Center,
Vaccinex (United States)
OpenAlex ID:
A5092705018
Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors
2022
·
Eriko Katsuta
, Malgorzata Gil‑Moore
, et al.
·
International Journal of Oncology
·
6
PDF
Use of poxvirus display to select antibodies specific for complex membrane antigens
2023
·
Ernest S. Smith
, Leslie A. Balch
, et al.
·
mAbs
·
2
PDF
Abstract LB-C007: Enhancing immune interactions in tumor with pepinemab SEMA4D blocking antibody
2026
·
Elizabeth E. Evans
, Crystal Mallow
, et al.
·
Cancer Immunology Research
Targeting SEMA4D/PLXN signaling through reactive glia as a common pathology for the treatment of neurodegenerative disorders
2025
·
Elizabeth E Evans
, Terrence L Fisher
, et al.
·
Alzheimer s & Dementia
PDF
1100 Discovery of high affinity functional antibodies specific for CXCR5, P2X7 and other multi-pass membrane receptors
2024
·
Ernest Smith
, Elizabeth Evans
, et al.
·
Regular and Young Investigator Award Abstracts
Show more works
View as search
Works count:
5
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type